Project Grant R21AI178135

Award Date 7/5/24
Completion Date 5/31/26
Dollars Obligated $471K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Galveston, TX 77555, USA

This $470,919 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to develop novel hamster models for studying chronic chikungunya virus (CHIKV) infection and disease progression. The University of Texas Medical Branch at Galveston (UTMB) is the prime recipient and will utilize CRISPR/Cas9 gene editing to generate hamsters deficient in type I and III interferon signaling pathways. These modified hamsters will be used to characterize CHIKV infection, tissue inflammation, vertical transmission, and the role of adaptive immunity in controlling chronic arthritis symptoms. The results are expected to refine a small animal model that better recapitulates the full spectrum of CHIKV disease in humans, including persistent arthralgia. The award period is from Jul 2024 to May 2026.

Generated 1/28/25, 7:41 AM